Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-07-23

Clinical Trial Update: Adjustable Continence Therapy (ACT) for the Treatment of Female SUI [NA]

View source ↗

Summary

Clinical trial update indicating that Adjustable Continence Therapy (ACT) is being studied for female stress urinary incontinence and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Adjustable Continence Therapy (ACT)

Snippet

Sponsor: Uromedica | Conditions: Urinary Incontinence, Urinary Incontinence,Stress | NA | Status: RECRUITING